Next-Generation Sequencing in Thyroid Cancer

Clinical Pearls

Marcia S. Brose, MD, PhD, assistant professor, Abramson Cancer Center at the University of Pennsylvania, discusses next-generation sequencing in thyroid cancer.

• Data have been inconclusive regarding the appropriate use of next-generation sequencing in thyroid cancer.
• Next-generation sequencing may help identify higher-risk patients.
• In most patients, care is clear from their pathology.
• There is clearly a role for next-generation sequencing in the advanced setting.